Craytheon

  • Financials
  • Screeners
  • Articles
  • Charts
  • Contact
  • Sign Up
  • Log In
 

Divis Laboratories Ltd. | DIVISLAB | NSE - Pharmaceuticals


Performance  |  Valuation  |  Growth  |  Insiders  |  Summary
Balance Sheet  |  Income Statement  |  Cash Flow  |  Quarterly

Financial Summary Report of Divis Laboratories Ltd.



DIVISLAB
Divis Laboratories Ltd.

Rs. 3315.30
31-Jan-2023

5 Yr Performance

    Upgrade Membership

1 Yr Performance

    Upgrade Membership

Valuation

    Upgrade Membership

Quarterly

    Upgrade to Professional Membership

Earnings Yield

    Upgrade to Professional Membership



Analysis


Upgrade to Professional Membership


Quarterly Revenue, Net Income and Adjusted Share Price



Upgrade to Professional Membership

Peer Comparison


AstraZenca Pharma India Ltd.

Aurobindo Pharma Ltd.

Biocon Ltd.

Cadila Healthcare Ltd.

Cipla Ltd.

RPG Life Sciences Limited

Dr. Reddy's Laboratories Ltd.

FDC Ltd.

Fresenius Kabi Oncology Ltd.

Glaxosmithkline Pharmaceuticals Ltd.


Annual Reports of Divis Laboratories Ltd.

Divis Laboratories Ltd.  2021 Annual Report.pdf

Divis Laboratories Ltd.  2020 Annual Report.pdf

Divis Laboratories Ltd.  2019 Annual Report.pdf

Divis Laboratories Ltd.  2018 Annual Report.pdf

Divis Laboratories Ltd.  2017 Annual Report.pdf

Divis Laboratories Ltd.  2016 Annual Report.pdf

Divis Laboratories Ltd.  2015 Annual Report.pdf

Divis Laboratories Ltd.  2014 Annual Report.pdf

Divis Laboratories Ltd.  2013 Annual Report.pdf




© Copyright 2021  All Rights Reserved.  Craytheon™

About  |  Testimonials  |  Terms of Use  |  Glossary  |  Blog